TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer

W Hua, P Ten Dijke, S Kostidis, M Giera… - Cellular and Molecular …, 2020 - Springer
Metastasis is the most frequent cause of death in cancer patients. Epithelial-to-mesenchymal
transition (EMT) is the process in which cells lose epithelial integrity and become motile, a …

ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism

C Granchi - European journal of medicinal chemistry, 2018 - Elsevier
ATP citrate lyase (ACLY) is a cytosolic homotetrameric enzyme that catalyzes the conversion
of citrate and coenzyme A (CoA) to acetyl-CoA and oxaloacetate, with the simultaneous …

Metabolic phenotyping in clinical and surgical environments

JK Nicholson, E Holmes, JM Kinross, AW Darzi… - Nature, 2012 - nature.com
Metabolic phenotyping involves the comprehensive analysis of biological fluids or tissue
samples. This analysis allows biochemical classification of a person's physiological or …

Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI

MK Andersen, TS Høiem, BSR Claes, B Balluff… - Cancer & …, 2021 - Springer
Background Prostate cancer tissues are inherently heterogeneous, which presents a
challenge for metabolic profiling using traditional bulk analysis methods that produce an …

[HTML][HTML] Lipid metabolism in prostate cancer

X Wu, G Daniels, P Lee, ME Monaco - American journal of clinical …, 2014 - ncbi.nlm.nih.gov
The malignant transformation of cells requires adaptations across multiple metabolic
processes to satisfy the energy required for their increased rate of proliferation …

A review of applications of metabolomics in cancer

RD Beger - Metabolites, 2013 - mdpi.com
Cancer is a devastating disease that alters the metabolism of a cell and the surrounding
milieu. Metabolomics is a growing and powerful technology capable of detecting hundreds …

Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer

S Ren, Y Shao, X Zhao, CS Hong, F Wang, X Lu… - Molecular & Cellular …, 2016 - ASBMB
Prostate cancer is a highly prevalent tumor affecting millions of men worldwide, but poor
understanding of its pathogenesis has limited effective clinical management of patients. In …

Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness

GF Giskeødegård, H Bertilsson, KM Selnæs, AJ Wright… - PloS one, 2013 - journals.plos.org
Separating indolent from aggressive prostate cancer is an important clinical challenge for
identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment …

Advances and perspectives in prostate cancer biomarker discovery in the last 5 years through tissue and urine metabolomics

AR Lima, J Pinto, F Amaro, ML Bastos, M Carvalho… - Metabolites, 2021 - mdpi.com
Prostate cancer (PCa) is the second most diagnosed cancer in men worldwide. For its
screening, serum prostate specific antigen (PSA) test has been largely performed over the …

Metabolic characterization of triple negative breast cancer

MD Cao, S Lamichhane, S Lundgren, A Bofin, H Fjøsne… - BMC cancer, 2014 - Springer
Background The aims of this study were to characterize the metabolite profiles of triple
negative breast cancer (TNBC) and to investigate the metabolite profiles associated with …